The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome
Open accessAbstract
Objective To determine if a relationship exists between the clinical features of Rett syndrome, an X-linked dominant neurodevelopmental disorder, and specific mutations in MECP2. Method Cross-sectional study of 245 girls and women with typical Rett syndrome seen between 1990 and 2004 in tertiary academic outpatient specialty clinics and who had complete MECP2 mutation analysis. A structured clinical evaluation was completed for each participant. The results were grouped by MECP2 mutation and compared. Results Participants with the R133C mutation are less severely affected than those with R168X or large DNA deletions (p Conclusions Specific mutations in MECP2 confer different severity. These results allow the design of therapies targeted toward the amelioration of expected problems. Furthermore, the distinct effects of MECP2 mutations on clinical severity must be considered in clinical intervention trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, MECP2 mutation status is a strong predictor of disease severity, but phenotype variation commonly occurs between individuals with the same MECP2 mutation and is attributed to differences in X chromosome inactivation (XCI) [97].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [38]
In the citing paper
“It is now well established that mutations in MECP2 account for 95% of typical RTT cases and commonly occur de novo [36–38].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [38]
In the citing paper
“It is now well established that mutations in MECP2 account for 95% of typical RTT cases and commonly occur de novo [36–38].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [38]
In the citing paper
“Rett syndrome (RTT) is a neurological disorder caused by mutations in the X-linked gene methyl-CpG-binding protein 2 (MECP2), a ubiquitously expressed transcriptional regulator.”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [38]
Citations
Cites
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Self-citationAllen, R. C., Zoghbi, H. Y., Moseley, A., Rosenblatt, H. M., & Belmont, J. W. (1992) · PubMed · Cited by 1,683
Self-citationAn update on clinically applicable diagnostic criteria in Rett syndrome
Hagberg, B. A., Hanefeld, F. A., Percy, A. K., & Skjeldal, O. H. (2002) · European Journal of Paediatric Neurology · doi:10.1053/ejpn.2002.0612 · Cited by 394
Self-citationInfluence of mutation type and X chromosome inactivation on Rett syndrome phenotypes
Amir, R. E., den Veyver, I. B. V., Schultz, R., Malicki, D. M., Tran, C. Q., Dahle, E. J., Philippi, A., Tímár, L., Percy, A. K., Motil, K. J., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5 · Cited by 351
Self-citationRett syndrome in Australia: A review of the epidemiology
Laurvick, C. L., de Klerk, N. H., Bower, C. I., Christodoulou, J., Ravine, D., Ellaway, C., Williamson, S. L., & Leonard, H. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.10.037 · Cited by 345
Williams syndrome: From genotype through to the cognitive phenotype
Donnai, D., & Karmiloff‐Smith, A. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(200022)97:2 · Cited by 314
Self-citationMECP2 mutations account for most cases of typical forms of Rett syndrome
Bienvenu, T. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1377 · Cited by 303
Cheadle, J. P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.7.1119 · Cited by 288
MECP2 is highly mutated in X-linked mental retardation
Couvert, P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.941 · Cited by 272
Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients
Huppke, P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1369 · Cited by 246
Research works printed but not linked: 1
- Zar JH. Biostatistical Analysis. In: Biostatistical Analysis. 4th ed. Englewood Cliffs NJ: Prentice-Hall; 1998: 564.
Cited by
Sorted by citations
Items 401–499 of 499
Variant Profile of MECP2 Gene in Sri Lankan Patients with Rett Syndrome
Hettiarachchi, D., Neththikumara, N. F., Pathirana, B. A. P. S., & Dissanayake, V. H. W. (2019) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-019-04230-7 · Cited by 2
Rett syndrome: Novel correlations linking >96% genotype, disease severity, and seizures
Rodriguez, L. M., Percy, A. K., & Cutter, G. (2020) · Translational Science of Rare Diseases · doi:10.3233/trd-200047 · Cited by 2
Self-citationCommunication Skills in Girls with Rett Syndrome
Bartolotta, T. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_195 · Cited by 2
Respiratory Disorders in Rett Syndrome
Spoto, G., Accetta, A. S., Grella, M. G., Modica, I. D., & Nicotera, A. G. (2024) · Current Respiratory Medicine Reviews · doi:10.2174/011573398x284907240426054522 · Cited by 2
Davis, T., Parab, P., May, D. M., & Ruetsch, C. R. (2023) · Future Rare Diseases · doi:10.2217/frd-2022-0022 · Cited by 1
Sal, A. D., Haumont, E., Pigeolet, M., Gaumé, M., Riouallon, G., Bahi‐Buisson, N., Linglart, A., Desguerre, I., Pannier, S., & Miladi, L. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030849 · Cited by 1
Lazek, R. A., Karoum, A., & Fathalla, W. M. (2025) · Cureus · doi:10.7759/cureus.86953 · Cited by 1
Rett syndrome: a complex disorder with promising therapeutic prospects
Sandakly, J., Frasca, A., & Landsberger, N. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.06.006 · Cited by 1
Natural history of epilepsy in FOXG1 Syndrome
Rhodes, C., Rees, B. W., Dubbs, H. A., Lesser, M., Morgan, L. E., Benke, T. A., Percy, A. K., Neul, J. L., & Marsh, E. D. (2025) · Epilepsy Research · doi:10.1016/j.eplepsyres.2025.107644 · Cited by 1
Self-citationHertzog, A., Tolun, A. A., Wykes, A. D., Brown, D. A., Breit, S. N., Ellaway, C., Ho, G., & Gold, W. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-20005-w · Cited by 1
Sato, M., Yamaki, H., Kawano, G., Tanaka, Y., Isooka, A., Yamashita, D., Akita, Y., Eshima, N., Takahashi, T., & Matsuishi, T. (2026) · Brain and Development · doi:10.1016/j.braindev.2026.104531 · Cited by 1
Melikishvili, M., Rea, M., Capan, C. D., Lee, H., Chandler, D. P., & Fondufe‐Mittendorf, Y. N. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113227 · Cited by 1
Molecular analysis of MECP2 gene in Egyptian patients with Rett syndrome
Zaki, M. S., El-Din, W. E. S., Hamdy, G. M., Kamal, I. H., & Aleem, A. K. A. (2011) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2011.11.004 · Cited by 1
Genotype–phenotype relationship among Egyptian children with Rett syndrome
Mansour, L., Elsobky, E. S., Mohamed, S. M., Marzouk, H., & Tarek, L. (2015) · Journal of the Egyptian Public Health Association · doi:10.1097/01.epx.0000469901.73624.7a · Cited by 1
Rett Syndrome: Seeing the Way Forward
Percy, A. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-18096-0_65 · Cited by 1
Self-citationThe Function of MeCP2 and Its Causality in Rett Syndrome
Lamonica, J. M., & Zhou, Z. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800109-7.00007-8 · Cited by 1
From Molecular Pathways to ASD Therapy: Insights from Syndromic Forms of Autism
Nicholls, L. E., Ramadas, R., & Voineagu, I. (2014) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814602167_0002 · Cited by 1
Non-canonical C-terminal variant of MeCP2 R344W exhibits enhanced degradation rate
Yue, C., Lee, S. S. Y., Shillington, A., Du, X., Fok, C. K. M., Yeung, K. C., Siu, G. K. Y., Yuan, S., Zheng, Z., Tsang, H. W. S., et al. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.09.007 · Cited by 1
Bricker, K., & Vaughn, B. V. (2024) · Sleep Medicine Research · doi:10.17241/smr.2024.02509 · Cited by 1
The Management of Bone Defects in Rett Syndrome
Caffarelli, C., & Gonnelli, S. (2025) · Calcified Tissue International · doi:10.1007/s00223-024-01322-0 · Cited by 3
Human MeCP2 binds to promoters and inhibits transcription in an unmethylated yeast genome
Brown, J. A. R., Ling, M. Y. M., Ausió, J., & Howe, L. J. (2025) · Genetics · doi:10.1093/genetics/iyaf043 · Cited by 1
Pathological Synaptic Plasticity in Neurological Disorders
Jin, C., & Karlstedt, K. (2025) · Synaptic Plasticity - Neurobiology, Neuroanatomy, and Clinical Neuroscience · doi:10.5772/intechopen.1007753 · Cited by 1
Zhang, S. (2016) · Digital Archive @ GSU · doi:10.57709/8486904 · Cited by 1
Application of Chromosome Conformation Capture (3C) to the Study of Human Genetic Disease
Horan, M. P., & Ballard, J. W. O. (2012) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0024383 · Cited by 1
Health-enhancing participation in girls and women with Rett syndrome - a balancing act
Stahlhut, M. (2018) · Lund University Publications (Lund University) · Cited by 1
Boilson, A. M. (2013) · Arrow@dit (Dublin Institute of Technology)
Rett syndrome and MECP2 and CDKL5 genotypes
Glaze, D. G. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511921001.036
Self-citationRett syndrome: Neurologic and metabolic aspects
Hagebeuk, E. E. O. (2013) · Data Archiving and Networked Services (DANS)
Lourenço, D. H. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/b5p4-vs81
Defining and Diagnosing Rett Syndrome: Correlating Symptoms and Pathogenesis with Autism
Percy, A. K., Chapleau, C., Lane, J. B., & Pozzo‐Miller, L. D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_88
Self-citationFoley, K. (2009) · Australasian Journal of Paramedicine
Maliszewska‐Cyna, E. (2010) · TSpace (University of Toronto)
Developing novel therapeutic strategies for Rett syndrome
Ross, P. D. (2016) · Enlighten: Theses (The University of Glasgow)
Developmental Delay: Gene Testing
Collins, C. D., Basehore, M. J., Champion, K. J., & Friez, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-19674-9_7
Cheung, A. Y. L. (2013) · TSpace (University of Toronto)
MECP2 duplication and mutations impair NSCs differentiation via miR-197 regulated ADAM10Preprint
Wang, Y.-M., Zheng, Y.-F., Yang, S.-Y., Yang, Z.-M., Zhang, L.-N., He, Y.-Q., Gong, X.-H., Liu, D., Finnell, R., Qiu, Z.-L., et al. (2018) · bioRxiv · doi:10.1101/312983 · Cited by 1
Rett Syndrome and Stem Cell Research
Tsujimura, K., & Nakashima, K. (2018) · Springer eBooks · doi:10.1007/978-3-319-90695-9_3
Franklin, D. (2018) · Advances in intelligent systems and computing · doi:10.1007/978-3-319-98702-6_4
平野, 大., & 谷口, 敬. (2019) · 日本重症心身障害学会誌 · doi:10.24635/jsmid.44.1_221
Loss of O-GlcNAcylation on MeCP2 Thr 203 Leads to Neurodevelopmental DisordersPreprint
Cheng, J., Zhao, Z., Chen, L.-P., Du, R., Wu, Y., Zhu, Q., Fan, M., Duan, X., & Wu, H. (2020) · bioRxiv · doi:10.1101/2020.06.17.158311
Kamdar, P., Thomas, M. M., Yoganathan, S., Muthusamy, K., Koshy, B., Oommen, S. P., Aaron, R., Barney, A. M., Abraham, S. S. C., & Danda, S. (2020) · Journal of Genetics · doi:10.1007/s12041-020-01244-4
Lung Defects Contribute to Respiratory Symptoms in a Mecp2-mutant Mouse Model of Rett Syndrome
Vashi, N. (2021) · TSpace (University of Toronto)
Percy, A. K. (2014) · Encyclopedia of the Neurological Sciences · doi:10.1016/b978-0-12-385157-4.01051-4
Self-citationTranscriptomic and epigenetic changes after the phenotypic rescue of a Rett Syndrome mouse model
Vargas-Landín, D. B. (2021) · UWA Profiles and Research Repository (UWA) · doi:10.26182/9kh2-8h70
Cianci, P., Picchi, R., Armano, C., & Selicorni, A. (2021) · Medico e Bambino · doi:10.53126/meb40519
Blagosklonny, M. V., & Gudkov, A. V. (2010) · Oncotarget · doi:10.18632/oncotarget.18947
Blagosklonny, M. V., & Gudkov, A. V. (2010) · Oncotarget · doi:10.18632/oncotarget.18942
Blagosklonny, M. V., & Gudkov, A. V. (2010) · Oncotarget · doi:10.18632/oncotarget.18953
Blagosklonny, M. V., & Gudkov, A. V. (2010) · Oncotarget · doi:10.18632/oncotarget.18940
Blagosklonny, M. V., & Gudkov, A. V. (2010) · Oncotarget · doi:10.18632/oncotarget.18794
Blagosklonny, M. V., & Gudkov, A. V. (2010) · Oncotarget · doi:10.18632/oncotarget.18944
Blagosklonny, M. V., & Gudkov, A. V. (2010) · Oncotarget · doi:10.18632/oncotarget.18938
Percy, A. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.04291-7
Self-citationRole of MeCP2 in oligodendrocyte lineage cells in Rett syndrome: review and inference
Zhang, Z., Li, P., & Chen, Y. (2023) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.13
The role of Methyl-CpG binding domain 3 (Mbd3) in epileptogenesisPreprint
Niźinska, K., Olszewski, M., Binias, S., Nowicka, D., Szydłowska, K., Nazaruk, K., Wojtaś, B., & Łukasiuk, K. (2023) · Research Square · doi:10.21203/rs.3.rs-3538252/v1
Síndrome de Rett en un lactante varón con variante patogénica en MECP2
Cote-Orozco, J. E., Córdoba, N. M., Rivera, I. L., & Córdoba-Gravini, J. L. (2023) · Revista Mexicana de Pediatría · doi:10.35366/114766
Galán‐Olleros, M., Alguacil, E. G., Insuga, V. M. S., Vara-Arias, M. T., Cabrera, N. V. O., Serrano, J. I., Egea-Gámez, R. M., Garcı́a-Peñas, J. J., Martínez-Caballero, I., Esteras, S. A., et al. (2024) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-024-06399-y
Rett syndrome: A coming of age
Percy, A. K. (2024) · Translational Science of Rare Diseases · doi:10.3233/trd-240069
Self-citationGioiosa, S., Gasparini, S., Presutti, C., Rinaldi, A., Castrignanò, T., & Mannironi, C. (2024) · Research Square · doi:10.21203/rs.3.rs-4895075/v1
Approach to diagnosis and management of genetic neurodevelopmental disorders
Mo, A., Oanea, M., Cohen, J. S., Rodan, L. H., & Srivastava, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824060-1.00002-x
2024 IRSF Rett Syndrome Scientific Meeting June 18-19, 2024, Westminster, Colorado, USA
Garg, N., Broccoli, V., Cobb, S., Meyer, K., & Pozzo‐Miller, L. D. (2024) · Translational Science of Rare Diseases · doi:10.1177/22146490241305261
Narita, H., Natsume, J., Suzuki, T., Shiohama, T., Kawaguchi, M., Okazaki, M., Hashizume, A., Naganawa, S., Ito, Y., Yamamoto, H., et al. (2025) · Brain and Development · doi:10.1016/j.braindev.2025.104348
Treatment of Neurodevelopmental Disorders
van Karnebeek, C., Berry‐Kravis, E., & Gropman, A. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00079-2
Altered oscillatory coupling reflects possible inhibitory interneuron dysfunction in Rett syndromePreprint
Kranz, D., Braverman, Y., McCarthy, M. M., Mackay, C. E., Sabol, K. N., Benke, T. A., Lieberman, D. N., Marsh, E. D., Neul, J. L., Peck, F. C., et al. (2025) · medRxiv · doi:10.1101/2025.07.21.25331927 · Cited by 1
Self-citationUllah, S. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06356-6
Rett Syndrome: Specific MECP2 Variants are Associated With Elevated Serum Neurofilament Light Chain
Hirn, E., Huppke, B., Wilken, B., Kiehntopf, M., & Huppke, P. (2025) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2025.07.016
Otani, Y., Goodall, E., Srinivasan, V., Ball, N. J., Barnett, S. F. H., Zech, T., Saarikangas, J., & Goult, B. T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.27.672337
Atypical Rett syndrome with chorea: a case report
Erdogan, M., Olinger, E. G., & Santos, S. F. (2025) · Acta Neurologica Belgica · doi:10.1007/s13760-025-02901-0
Biomarkers of Lipid Oxidative Damage in Rett Syndrome
Felice, C. D., Signorini, C., Leoncini, S., Pecorelli, A., Durand, T., Galano, J., Oger, C., Bultel‐Poncé, V., Valacchi, G., Ciccoli, L., et al. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_197
Neul, J. L., Benke, T. A., Marsh, E. D., Suter, B., Silveira, L., Fu, C., Peters, S. U., & Percy, A. K. (2024) · Figshare · doi:10.6084/m9.figshare.24310000
Self-citationMay, D. M., Kponee-Shovein, K., Neul, J. L., Percy, A. K., Mahendran, M., Downes, N., Chen, G., Watson, T., Pichard, D. C., Kennedy, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26754100
Self-citationKostanian, D. G., Rebreikina, A. B., Voinova, V., & Sysoeva, O. (2023) · Figshare · doi:10.6084/m9.figshare.24447530
Neul, J. L., Benke, T. A., Marsh, E. D., Suter, B., Silveira, L., Fu, C., Peters, S. U., & Percy, A. K. (2023) · Figshare · doi:10.6084/m9.figshare.24309896
Self-citationAdditional file 1 of Cortisol profiles and clinical severity in MECP2 duplication syndrome
Peters, S. U., Fu, C., Neul, J. L., & Granger, D. A. (2020) · Figshare · doi:10.6084/m9.figshare.12695574
Self-citationMohammed, H. E., Bady, Z. A. M., Haseeb, M. E., Aboeldahab, H. A., Sharaf-Eldin, W. E., & Zaki, M. S. (2024) · Figshare · doi:10.6084/m9.figshare.26322596
Advances in Stem Cell Research for MECP2-Related Disorders
Akaba, Y., Takahashi, S., & Tsujimura, K. (2025) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-031-94101-6_2
Transcranial Photobiomodulation in Rett Syndrome: A Mechanistic Review and Therapeutic Hypothesis
Luchese, F., Lohmann, C., Ferreras, B. I., & Cassano, P. (2026) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1177/25785478251415480
Simonnet, C. (2019) · theses.fr (ABES) · doi:10.70675/dcc67be7z8c6dz47b5z92e8z4d75367bfd48
Syndrome de Rett et implication des organes périphériques : de la physiopathologie à la thérapie
Borloz, E. (2021) · theses.fr (ABES) · doi:10.70675/6910a242za2edz4509zbc5aze548081377dd
Etude de la contribution de l'hormone adipocytaire leptine dans la pathogenèse du syndrome de Rett
Belaïdouni, Y. (2022) · theses.fr (ABES) · doi:10.70675/f69d2875zfa9fz4465z917eza8e7b93935c6
Atypical social behaviors in mouse models for Rett syndrome
Acevedo-Triana, C. A., Medeiros, D., Gonçalez, J. L., Li, W., & Pozzo‐Miller, L. D. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1744450
Prange, E. O., Fleysh, D., Reddy, K., Dubbs, H. A., & Marsh, E. D. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1776146
Booalizadeh, P., Salahshourifar, I., Rabbani, B., Rezvani, M., Ashrafi, M. R., & Mahdieh, N. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02545-6
Rett syndrome lifespan extension in mice via AI-guided ADAR editingPreprint
Savva, Y. A., Booth, B. J., Shumaker, L. R., Fasnacht, R. D., Burleigh, S. M., Jiang, Y., Cao, Y., Johnson, B., Bagepalli, L. R., Golic, F., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.23.734060
Recent advances in epigenetic therapeutics for Rett syndrome: from mechanisms to clinical trials
Zhao, C., Huang, Z., Li, R., Hua, L., Li, H., & Wang, B. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1835425 · Cited by 1
Bayramcı, N. S., & Yavuz, D. (2026) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub1358.c5468
Raniolo, L. N., Braden, R. O., von Hehn, J., Christodoulou, J., Lieberman, D. N., Amor, D. J., & Vogel, A. P. (2026) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.70429
Carotid body dysfunction contributes to respiratory instability in Rett syndrome
Strain, M. L., da Silva, E. N., Olsen, M. L., & Mulkey, D. K. (2026) · Current Biology · doi:10.1016/j.cub.2026.08.015
Structures of MeCP2 bound to nucleosomes reveal distinct mechanisms of Rett syndrome mutationsPreprint
Yao, L., Valderrama-Hincapié, C., Song, J., Kelly, I., Chuong, E. B., & Kasinath, V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.08.750195
Fenfluramine in Rett syndrome: A multidimensional clinical study
Alguacil, E. G., Casanova, N. L., Luján-Bonete, M., Mansilla-Lozano, D., Garcı́a-Peñas, J. J., Ballarà-Petitbò, M., Trincado-Lamuño, R., Extremera, V. C., Conejo, R. D., Sánchez, C. R., et al. (2026) · Epilepsia Open · doi:10.1002/epi4.70355
Pulles, T., Jenner, B., van den Berg, M., Rocha, P., Martini, A. D., Chamberlain, K., & Grandjean, H. (2026) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-026-04651-5
Khan, M., RUTTER, M., Thapar, A., & Yuen, R. K. C. (2026) · Wiley eBooks · doi:10.1002/9781394389933.ch16
Clinical management of Rett syndrome
Halbach, N. S. J. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20130605nh
Neuroprostanes and Neurological Severity in Rett Syndrome
Felice, C. D., Leoncini, S., Signorini, C., Pecorelli, A., Durand, T., Galano, J., Guy, A., Valacchi, G., Ciccoli, L., & Hayek, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_198
Metadata
- Authors
- Neul, J. L., Fang, P., Barrish, J., Lane, J., Caeg, E. B., Smith, E. O., Zoghbi, H., Percy, A., & Glaze, D. G.
- Affiliations
- University of Alabama (US)
- Venue
- Neurology
- Published
- 2008-04-15
- Volume
- 70
- Issue
- 16
- Pages
- 1313-1321
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC2677974
- OpenAlex
- W2066619092
- Cited by
- 498
- References
- 38
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 45 · 2023: 33 · 2022: 23 · 2021: 35 · 2020: 29 · 2019: 24 · 2018: 24 · 2017: 27 · 2016: 30 · 2015: 29 · 2014: 23 · 2013: 33 · 2012: 20
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Alabama at Birmingham
- National Institute of Neurological Disorders and Stroke (K08NS052240, NS057819, T32NS043124, NS43124, NS052240, R01NS057819)
- National Center for Research Resources (U54RR019478, RR-019478, RR 00188, K01RR000188, M01RR000188)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-38985, P30HD038985, HD40301, P01HD040301)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- Rett syndrome, MECP2 mutations, clinical severity, DNA deletion, ambulation, hand use, language development
- MeSH terms
- Cross-Sectional Studies, Female, Humans, Mutation, Severity of Illness Index, Rett Syndrome, Methyl-CpG-Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review